Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... annual meeting of the European Society of Human reproduction and Embryology (ESHRE) in Amsterdam, The ... presentation at 25th European Society of Human reproduction and Embryology (ESHRE) on June 29, 2009. ... presentation at 25th European Society of Human reproduction and Embryology (ESHRE) on June 29, 2009 . ...Unisense FertiliTech A/S Receives CE Mark of Approval for EmbryoScope(TM) Embryo Monitoring System
... A/S says, "the CE mark will allow us to market the instrument to Assisted reproduction clinics across Europe, with the goal of improving embryo assessment and to ... EmbryoScope(TM) Embryo Monitoring System at the European society of Human reproduction and Embryology in Amsterdam, June 29.July 1 2009 Unisense ...Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced
... GrAnt (FRIGGA) are announced today at the European Society for Human reproduction & Embryology Congress. The two winners of this new prize are the ... Euros is a Clinical Embryologist and researcher in the Department of reproduction and Gynaecology, University Medical Centre Utrecht (UMC Utrecht). UMC ...AspenBio Pharma Reports Second Quarter 2007 Results
... drugs continue to demonstrate their cost effectiveness in enhancing the reproduction process and maintaining improved pregnancy rates. If successfully approved ... to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and ...Microbix Sales Grow 22% For Nine Months
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto. This press release contains forward-looking statements, which are ...Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Mississauga. This press release contains forward-looking statements, which are ...New IVF Software MedITEX to be Presented at the ESHRE Exhibition
... solutions, is set to present its new software for in vitro fertilisation, MedITEX IVF, at the 25th Annual Meeting of the European Society of Human reproduction and Embryology (ESHRE) to be held in Amsterdam from 28 June to 1 July. The software solution is the only officially approved program in Germany for ...Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto. This press release contains forward-looking statements, which are ...International science consortium publishes analysis of domestic cattle genome sequence
... the domestic cattle genome, researchers found that some of these chromosomal rearrangements affect genes related to immunity, metabolism, digestion, reproduction and lactation. For instance, researchers think some of these changes may explain the unique ability of cattle to convert grass and other low-energy ...Microbix Announces A New Technology Platform For The SST Project
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto. This press release contains forward-looking statements, which are ...Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto. This press release contains forward-looking statements, which are ...Eklin Signs Letter of Intent With ZONARE for Distribution of Zone Sonography(TM) z.one System
... offers cardiac function analysis and the T9-4 allows intercostal access in tight areas, such as between the ribs. Designed specifically for equine reproduction is ZONARE's high performance, reproductive probe. Numerous other transducers are also available. Additionally, the z.one system's ...Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
... them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto. This press release contains forward-looking statements, which are ...LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
... The technology license agreement covers a number of the universities' unique technologies and innovations, including improvements in livestock reproduction and a treatment for Alzheimer's disease. Details on these and other technologies are expected to be disclosed later this year. LGE Execs and TTUS are ...JCI table of contents: April 22, 2008
... attached to LH have a crucial role in regulating the levels of this hormone in the blood. TITLE: Ablation of GalNAc-4-sulfotranferase-1 enhances reproduction by altering the carbohydrate structures of luteinizing hormone in mice AUTHOR CONTACT: Jacques U. Baenziger Washington University School of ...Solving the Z ring's mysteries may lead to new antibiotics
... A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics. In a recent study published in the journal Current Biology, the scientists ...AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...Launch of New, Prestigious Infertility and Gynaecology Research GrAnt (FRIGGA)
... Two grants to the value of euros 50,000 each will be awarded with the announcement of first recipients of the awards at the European Society of Human reproduction and Embryology (ESHRE) congress in Barcelona (6 - 9 July 2008). The deadline for the submission of grant applications is 30 April 2008. The award ...AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...AspenBio Pharma Announces $18 Million Private Placement of Common Stock
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...AspenBio Pharma to Present the Edgewater Research Investor Conference
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and ...AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to make exciting progress in the ...AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY'
... successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to make exciting progress in the ...Ashcroft announces first FBI raid on file-sharing network
... is a civil matter, but becomes criminal and thus the domain of the Department of Justice if it is conducted for financial gain or involves the reproduction or distribution of more than $1,000 worth of materials within 180 days. The Recording Industry Association of America separately announced ...UW stem cell guru outlines scientific and political future
... cell research] for many reasons, he said. For example, the mouse does not use a corpus luteum in reproduction, a major failing for replicating human reproduction processes. Another problem with adult stem cells is that heart cells dont divide in the laboratory, and healthy heart tissue is difficult to ...UN committee opposes human cloning
... UN action," she said. Many nations, including France and Germany, have taken the worldwide legislative lead on the issue by outlawing cloning for reproduction or research purposes in addition to banning inheritable genetic modification (IGM). The United States allows cloning for purposes of research and has ...Amendment on cloning ban rejected; vote on bill set for Wednesday
... field of science. The amendment, offered by state Sen. Alberta Darling, R-River Hills, would have prohibited cloning for the purposes of human reproduction while still allowing for research cloning, creating what Darling said would have been a bill that could pass with widespread support and be signed ...Wisconsin Senate votes to outlaw cloning; measure still faces veto
... cloning' and `therapeutic cloning,'" said Peggy Hamill, Pro-Life Wisconsin's state director, speaking through a press release. "Both involve the reproduction of a fully human life. The immediate product of somatic cell nuclear transfer - the cloning process - is a human person, whether the intent is to ...Fact and friction: Putting election-year stem cell claims under the microscope
... so it's silly to suggest he aspires to create a mini-Frankenstein. But he supports what is called "therapeutic cloning," which is the asexual reproduction of stem cells to make other stem cells for research purposes. Green and others say therapeutic cloning is tantamount to cloning a human being if ...